US Edition
Large Multinational Trial Underway to Determine if CBD May Improve Behavioral Issues in People With Tuberous Sclerosis
Summary by The Marijuana Herald
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Large Multinational Trial Underway to Determine if CBD May Improve Behavioral Issues in People With Tuberous Sclerosis
The Marijuana Herald - Marijuana news and information A large international trial is underway to determine whether CBD can help improve behavioral symptoms in people with tuberous sclerosis complex (TSC), a condition that affects about 90% of patients with a group of neuropsychiatric symptoms known as TAND. The study, called EpiCom, is a phase 3b/4 open-label trial taking place at around 20 sites across the United States, United Kingdom, Canada,…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
